Prenetics Global GAAP EPS of -$1.58, revenue of $5.9M

Stock Information for Prenetics Global Limited

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Prenetics Global Limited

Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board
Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction
Prenetics Announces First Quarter 2025 Financial Results, Raises FY2025 Outlook, & Crypto Strategy Announcement Soon
IM8 Vibrante Miami: Fueling Wellness and Innovation with a Star-Studded Event
Prenetics' IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market
Prenetics to Participate in the 37th Annual ROTH Conference
Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance
Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.